Biosplice Therapeutics - Crunchbase Company Profile & Funding
These Are The US Startups That Russian Investors Are Backing
Biosplice Therapeutics - Crunchbase Company Profile & Funding. The company asserts that medicines that can harness this process will help cure musculoskeletal, ummune and oncological disorders. Summary financials people technology signals & news similar companies.
These Are The US Startups That Russian Investors Are Backing
Stemming from foundational discoveries in wnt pathway modulation, biosplice has elucidated novel biology linking clk/dyrk kinases to the therapeutic regulation of alternative splicing. Ics is an ibm and salesforce software developer and consulting company. Scorpion therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients. Biosplice therapeutics has produced fresh biological insights and unique chemical equity that delivers therapeutic modulation of alternative splicing by targeting the clk/dyrk family kinases. Biosplice therapeutics is an american pharmaceutical company engaged in the development of alternative splicing technologies. 11 rows biosplice therapeutics has raised a total of $799m in funding over 6 rounds. Onal discoveries in wnt pathway modulation, biosplice has elucidated novel biology linking clk/dyrk kinases to the therapeutic regulation of alternative splicing. Ics is an ict company that provides software and system products. Summary people technology signals & news similar companies. Summary people technology signals & news similar companies.
Onal discoveries in wnt pathway modulation, biosplice has elucidated novel biology linking clk/dyrk kinases to the therapeutic regulation of alternative splicing. 2 age (years) $270m total funding. The company asserts that medicines that can harness this process will help cure musculoskeletal, ummune and oncological disorders. Biosplice therapeutics has produced fresh biological insights and unique chemical equity that delivers therapeutic modulation of alternative splicing by targeting the clk/dyrk family kinases. Funding stage early stage venture. Companies like biosplice therapeutics include twist. Biosplice therapeutics has produced fresh biological insights and unique chemical equity that delivers therapeutic modulation of alternative splicing by targeting the clk/dyrk family kinases. This profile is based on publicly available information. Ics is an ibm and salesforce software developer and consulting company. Summary financials people technology signals & news similar companies. List of biosplice therapeutics 's 6 funding rounds from 12 investors.
